1. Ubiquitin Specific Peptidase 22 Regulates Histone H2B Mono-Ubiquitination and Exhibits Both Oncogenic and Tumor Suppressor Roles in Cancer
   Lucile Jeusset et al, 2017, Cancers CrossRef
2. Deubiquitinating enzymes as oncotargets
   Urszula L. McClurg et al, 2015, Oncotarget CrossRef
3. Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review
   Abdelhakim Bouyahya et al, 2022, Pharmaceuticals CrossRef
4. p38 mitogen-activated protein kinase inhibits USP22 transcription in HeLa cells
   JIANJUN XIONG et al, 2015, Biomedical Reports CrossRef
5. Pirarubicin reduces USP22 expression by inhibiting CREB‑1 phosphorylation in HeLa cells
   Xiaoou Zhou et al, 2019, Experimental and Therapeutic Medicine CrossRef
6. Ubiquitin-specific peptide 22 acts as an oncogene in gastric cancer in a son of sevenless 1-dependent manner
   ChitChoon Lim et al, 2020, Cancer Cell International CrossRef
7. USP22 controls necroptosis by regulating receptor‐interacting protein kinase 3 ubiquitination
   Jens Roedig et al, 2021, EMBO reports CrossRef